Analysis of cardiovascular ultrasound and clinically relevant risk factors in ischemic stroke
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Background
Current ischemic stroke (IS) risk stratification primarily relies on conventional clinical factors, while the incremental value of cardiovascular ultrasound markers remains unclear. We aimed to evaluate the synergistic effect of integrating cardiovascular ultrasound markers with clinical risk factors for IS prediction.
Methods and Results
This retrospective case-control study enrolled 210 IS patients (59.0±12.4 years, 67.6% men) and 210 age- and sex-matched controls (57.0±12.3 years, 71.0% men) from Sichuan Provincial People’s Hospital (2018–2021). We collected comprehensive demographic, serological, and ultrasonographic data. In the multivariable Logistic regression analysis, elevated diastolic blood pressure (odds ratio [OR] 1.032, 95% CI 1.003–1.063, P = 0.030), hypertriglyceridemia (OR 2.252, 95% CI 1.554–3.264, P < 0.001), smoking history (OR 1.938, 95% CI 1.091–3.442, P = 0.024), carotid plaque grades 2–3 (OR 3.402, 95% CI 1.653–8.355, P = 0.001; OR 14.242, 95% CI 6.055–33.499, P < 0.001), and left ventricular diastolic dysfunction grades 2–3 (OR 3.053, 95% CI 1.116–33.499, P = 0.030; OR 18.366, 95% CI 1.761–191.552, P = 0.015) are independent predictors of IS. We evaluated the diagnostic performance and clinical utility of different joint indices. Joint Index 4, incorporating ultrasound and clinical factors, demonstrated robust predictive performance with further incremental value (area under the curve [AUC] 0.887, 95% CI 0.857–0.918, P < 0.001; sensitivity 81.4%, specificity 81.0%), thereby improving correct management decisions.
Conclusion
The integration of cardiovascular ultrasound markers with clinical risk factors could improve IS risk stratification, offering a comprehensive tool for clinical decision-making.
CLINICAL PERSPECTIVE
What Is New?
This study is the first to propose the novel Joint Index 4—which integrates clinical risk factors, left ventricular diastolic dysfunction (LVDD) grading, and carotid plaque grading—demonstrates superior predictive performance for IS risk compared to traditional clinical models with further incremental value.
These imaging biomarkers address the limitations of existing IS risk stratification tools by identifying subclinical cardiovascular abnormalities, such as LVDD and advanced atherosclerosis.
What Are the Clinical Implications?
This study redefines high-risk IS populations by integrating traditional clinical risk factors with cardiovascular ultrasound markers, offering a cost-effective, noninvasive risk-stratification tool for early intervention.
